Legal Representation
Attorney
CHERYL FOYTLIN
USPTO Deadlines
Application History
25 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jan 23, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Jan 23, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Jun 21, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jun 17, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jun 17, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Jun 17, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Dec 16, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Dec 14, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Dec 14, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Dec 14, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jun 23, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jun 21, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jun 21, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jun 21, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Dec 22, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Oct 27, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 27, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Oct 7, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Sep 23, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
May 21, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
May 21, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
May 21, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
May 19, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Mar 24, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Mar 23, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infection-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; anti-allergics; vaccines
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005